HPV is also known as human papillomavirus, which has many subtypes, divided into high-risk and low-risk types. high-risk HPV is closely related to the development of cervical cancer, while low-risk HPV is closely related to the development of condyloma acuminata, and The onset of disease is associated with reduced immunity of the body. Therefore, it is recommended that high-risk groups can receive HPV vaccine to prevent cervical cancer, but HPV vaccine is not a panacea and only prevents cervical cancer caused by several subtypes of HPV infection.